Recalls from McKesson

• Hikma Gemcitabine Injection (opens in a new tab)
  Moderate risk, FDA, Jul 1, 2026, Processing problem
• Accord BioPharma Udenyca Prefilled Syringe (opens in a new tab)
  High risk, FDA, Feb 10, 2026, Processing problem

Data: Recall Canary (opens in a new tab)